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Background: The purpose of this study was to demonstrate the potential of magnetic poly(methyl 
methacrylate) (PMMA) core/polyethyleneimine (PEI) shell (mag-PEI) nanoparticles, which pos-
sess high saturation magnetization for gene delivery. By using mag-PEI nanoparticles as a gene 
carrier, this study focused on evaluation of transfection efficiency under magnetic induction. The 
potential role of this newly synthesized nanosphere for therapeutic delivery of the tryptophan 
hydroxylase-2 (TPH-2) gene was also investigated in cultured neuronal LAN-5 cells.
Methods: The mag-PEI nanoparticles were prepared by one-step emulsifier-free emulsion 
polymerization, generating highly loaded and monodispersed magnetic polymeric nanoparticles 
bearing an amine group. The physicochemical properties of the mag-PEI nanoparticles and 
DNA-bound mag-PEI nanoparticles were investigated using the gel retardation assay, atomic 
force microscopy, and zeta size measurements. The gene transfection efficiencies of mag-PEI 
nanoparticles were evaluated at different transfection times. Confocal laser scanning microscopy 
confirmed intracellular uptake of the magnetoplex. The optimal conditions for transfection of 
TPH-2 were selected for therapeutic gene transfection. We isolated the TPH-2 gene from the 
total RNA of the human medulla oblongata and cloned it into an expression vector. The plasmid 
containing TPH-2 was subsequently bound onto the surfaces of the mag-PEI nanoparticles via 
electrostatic interaction. Finally, the mag-PEI nanoparticle magnetoplex was delivered into 
LAN-5 cells. Reverse-transcriptase polymerase chain reaction was performed to evaluate TPH-2 
expression in a quantitative manner.
Results: The study demonstrated the role of newly synthesized high-magnetization mag-PEI 
nanoparticles for gene transfection in vitro. The expression signals of a model gene, luciferase, 
and a therapeutic gene, TPH-2, were enhanced under magnetic-assisted transfection. An in vitro 
study in neuronal cells confirmed that using mag-PEI nanoparticles as a DNA carrier for gene 
delivery provided high transfection efficiency with low cytotoxicity.
Conclusion: The mag-PEI nanoparticle is a promising alternative gene transfection reagent 
due to its ease of use, effectiveness, and low cellular toxicity. The mag-PEI nanoparticle is 
not only practical for gene transfection in cultured neuronal cells but may also be suitable for 
transfection in other cells as well.
Keywords: magnetic nanoparticle, non-viral vector, gene delivery, tryptophan hydroxylase-2, 
LAN-5, neuronal cells
Introduction
Magnetic nanoparticles have previously been used in biomedical applications, especially 
in the area of medical imaging,1 and drug and gene delivery.2 Magnetic-assisted gene 
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transfection could improve transfection efficiency by using 
magnetic force induction to introduce a therapeutic gene into 
a target cell. Application of an external magnetic field for gene 
delivery was first reported by Mah et al.3 Magnetic micropar-
ticles were coated with adenoassociated virus encoding green 
fluorescent protein. It was demonstrated that adenoassociated 
virus conjugated with magnetic microparticles enhanced 
transduction efficiency both in vitro and in vivo. Since then, 
several intensive studies of magnetic-based gene delivery 
have been performed.4,5 Magnetic-assisted gene delivery 
can be applied to transfection reagents and gene therapeutic 
vehicles, and the first report focusing on the use of magnetic-
assisted targeted gene delivery used polyethyleneimine (PEI)-
coated nanoparticles for in vitro gene transfection.6 The study 
demonstrated the advantages of magnetic-assisted transfec-
tion in terms of reducing incubation time and DNA dose. To 
date, magnetic-assisted transfection has been demonstrated 
as one of the approaches for nucleic acid transfer, includ-
ing DNA and RNA interference, in various cell lines. For 
example, the combination of cationic lipid-coated magnetic 
nanoparticles with transferrin and PEI was developed for 
transfection in a human cervical cancer cell line. This sys-
tem enhanced the transfection efficiency by approximately 
300-fold compared with control transfection reagents in the 
presence of an external magnetic field.5 A hybrid nanoparticle 
system consisting of superparamagnetic nanoparticles and 
PEI was used as a vehicle to transfer the interleukin-10 gene 
into vascular endothelial cells.4 This particle showed high 
transgene expression using a very low vector concentration 
and in a very short incubation time. This system is promising 
for treatment of patients with vascular disorders who require 
fast and target-specific delivery of the genes concerned. Apart 
from being an effective transfection reagent, incorporation of 
magnetic nanoparticles into lipid-based or polymeric-based 
carriers has also been considered as an alternative approach 
for improvement of non-viral vector-based gene therapy.7,8 
At present, many research groups are aiming to develop a 
vehicle which could facilitate gene therapy in several genetic 
disorders, including the hematological,9 cardiovascular,10 and 
immunogenic systems.11
Non-viral approaches for nucleic acid delivery have also 
become a novel strategy for treating neurological disease.12 
Neuron-targeted nucleic acid therapy remains one of the 
few options available for the treatment of neurodegenerative 
disease. In previous studies, viral vectors were used as the 
gene carrier for transfer of nucleic acid into target neuron 
cells, and adenoassociated virus was the most common 
viral vector for gene transfection.13–15 However, there has 
been a recent focus on non-viral vector-based gene vectors 
for neuron systems, with some reported examples, includ-
ing lipid-based and polymeric-based carriers. PEGylated 
immunoliposome-mediated brain-specific delivery of a gene 
encoding tyrosine hydroxylase for the treatment of patients 
with Parkinson’s disease has been studied successfully in 
an animal model.16 Modified transfection reagents, ie, PEI-
PEG and Tet1 complexes, demonstrated increased luciferase 
expression levels in neural progenitor cells compared with 
unmodified PEI-PEG complexes.17
In this study, we investigated the use of novel synthesized 
magnetic nanoparticles for gene delivery in neuronal cells. 
Magnetic PEI/poly(methyl methacrylate) (PMMA) core-shell 
(mag-PEI) nanoparticles were prepared using ultrasonication-
assisted emulsifier-free emulsion polymerization. Loading of 
magnetic nanoparticles enhanced gene transfection efficiency 
by accelerating the cellular uptake of nanoparticles. The 
physicochemical properties and morphology of the mag-PEI 
nanoparticles were characterized, and a feasibility study was 
performed to evaluate the gene transfection efficiency of the 
mag-PEI nanoparticles using plasmid pGL3-basic containing 
cytomegalovirus (CMV) promoter/enhancer encoding the 
luciferase reporter gene (pGL3-CMV). In vitro transfection 
of pGL3-CMV could be measured quantitatively using the 
luciferase assay system. Different N/P ratios of magnetoplex 
were prepared to investigate the transfection efficiency 
at different transfection times with and without magnetic 
induction. The cytotoxicity of the mag-PEI nanoparticles was 
examined using the MTT assay. Transfection under magnetic 
induction strongly promotes cell internalization, as shown by 
confocal laser scanning microscopy. Optimal conditions were 
selected for transfection of pGL3-CMV , a plasmid containing 
tryptophan hydroxylase-2 (TPH-2), a rate-limiting enzyme 
for production of the serotonin neurotransmitter.18 This study 
proposes an alternative nanocarrier, which is applicable for 
neuronal gene therapy.
Materials and methods
Materials
Ferrous chloride tetrahydrate (FeCl2 ⋅ 4H2O), ferric chloride 
hexahydrate (FeCl3 ⋅ 6H2O), methyl methacrylate (MMA), 
and t-butyl hydroperoxide were purchased from Fluka 
(St Louis, MO). PEI (molecular weight of 25 kDa) was 
  purchased from Sigma-Aldrich (St Louis, MO). All chemi-
cals were of analytical grade and used for synthesis of mag-
netic core/shell nanoparticles. Lipofectamine 2000™ was 
purchased from Invitrogen (Carlsbad, CA). A PolyMAG and 
  magnetoFACTOR-96 plate was purchased from Chemicell 
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GmbH (Berlin, Germany). Plasmid pGL3-basic containing 
CMV promoter/enhancer, which is an expression vector for 
human cell lines, was used to monitor transfection   efficiency.19 
Plasmid DNA was propagated in Escherichia coli, which 
were grown in Lysogeny broth (10 g/L tryptone, 5 g/L yeast 
extract, and 10 g/L NaCl), and supplemented with ampicillin 
under shaking conditions of 250 rounds per minute at 37°C. The 
plasmid was extracted using the PureLink™ Hipure   Plasmid 
DNA purification kit (Invitrogen). The extracted plasmid 
was observed by electrophoresis on 1.0% agarose gel. 
Plasmid purity and concentration were determined by 
measuring light absorbance at 260 nm and 280 nm using a 
SpectraMax M2 microplate reader (MDS Inc, Sunnyvale, 
CA). Primers for reverse-transcriptase polymerase chain 
reaction (RT-PCR) of GAPDH and TPH-2 genes are listed 
in Table 1.
Preparation of magnetic  
core/shell nanoparticles
Mag-PEI nanoparticles with a PMMA core and PEI shell 
were prepared by emulsion polymerization.20 In brief, iron 
oxide at a concentration of 25 mg was dispersed thoroughly 
with 2 g of MMA using an ultrasonicator for 5 minutes. For 
a total of 50 g of solution, the iron oxide-MMA dispersion 
was mixed with 47 g of PEI solution containing 0.5 g of PEI 
using a homogenizer (Sonics Vibra cell, amplitude 40%). The 
dispersion was homogenized for 15 minutes and then trans-
ferred into a water-jacketed flask equipped with a condenser, 
a magnetic stirrer, and a nitrogen inlet. The dispersion was 
purged with nitrogen for 30 minutes, followed by addition 
of t-butyl hydroperoxide aqueous solution (1 g, 0.5 mM) to 
initiate polymerization. The mixture was then continuously 
stirred at 80°C for 2 hours in a nitrogen environment. After 
the reaction, the particle dispersion was purified by repeated 
centrifugation (13,000 rpm), decantation, and redispersion 
until the conductivity of the supernatant was close to that of 
the distilled water used. The amine density on the surface 
of the nanoparticles was evaluated using a typical acid-base 
titration method.21 The titration was carried out with an 
Autotitrator (Mettler Toledo, T50, Columbus, OH) and a 
pH glass sensor (Mettler Toledo, DGi115-SC) using 0.01 M 
NaOH standardized by potassium hydrogen phthalate as a 
titrant. The sample preparation was performed using an aque-
ous solution composed of 0.5 mL of the sample suspension 
(30–40 mg/mL), 50 mL of deionized water, and 0.40 mL of 
0.1 M HCl. Each value reported was an average of at least 
three measurements. The characteristics of mag-PEI nano-
particles were then observed through a transmission electron 
microscope at an accelerating voltage of 80 kV .
Preparation of magnetoplex
For the feasibility study of mag-PEI nanoparticles in 
gene delivery, plasmid DN and pGL3-CMV encoding the 
luciferase reporter gene at a concentration of 1 mg/mL was 
mixed with mag-PEI nanoparticles at the same concentra-
tion to form the mag-PEI nanoparticle/DNA magnetoplex. 
The magnetoplex was prepared at various N/P ratios, ie, 
0.4/1, 0.8/1, 1.6/1, 4.3/1, 8.7/1, and 17.5/1. The solutions of 
magnetoplex were subsequently incubated at room tempera-
ture for 30 minutes before use. The optimal N/P ratio from 
pGL3-CMV transfection was used for pGL3-CMV-TPH-2 
transfection, in which the magnetoplex was prepared in the 
same manner.
Gel retardation assay
After forming the magnetoplex, loading dye was added and 
mixed before loading into 1.0% agarose gel. Electrophoresis 
was carried out at 100 V for 60 minutes. Agarose gel was 
stained in 1 µg/mL ethidium bromide. The presence of plas-
mid DNA was visible under an ultraviolet transilluminator 
(Syngene, Cambridge, UK). The shifted bands, correspond-
ing to free plasmid, were determined.
Atomic force microscopy analysis
Atomic force microscopic images of magnetoplex were 
obtained using a dynamic force microscope (Seiko SPA4000, 
Table 1 Polymerase chain reaction primers used for tryptophan hydroxylase-2 cloning and semiquantitative assay of GAPDH and 
tryptophan hydroxylase-2 gene expressions
Primer Sequence Product (Kb) Reference
TPH-2-NheI_pGL-CMV 5′-CCT gCT AgC gCC TTC CTC TCA ATC TC-3′ 1.5 The present study
TPH-2-XbaI_pGL-CMV 5′-CCC gCT CTA gAT AgT TCC Agg CAT CAA ATC C-3′
GAPDH sense 5′-gAC CAC AgT CCA TgC CAT CAC T-3′ 0.4 Divya and Pillai22
GAPDH antisense 5′-TCC ACC ACC CTg TTg CTg TAg-3′
TPH-2 sense 5′-AAC CAC TAT TgT gAC gCT gAA TCC TCC AgA gAA-3′ 0.2 The present study
TPH-2 antisense 5′-ACC CAT AAC CCA TCg CCA CAT CCA CAA AA-3′
Abbreviations: CMV, cytomegalovirus; TPH-2, tryptophan hydroxylase-2.
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Tokyo, Japan). All samples were prepared by dropping the 
magnetoplex solution onto a mica surface for air-drying. All 
images were obtained with a scanning speed of 1.0 Hz over 
a 2 µm × 2 µm area.
Size and zeta potential analysis
The mean zeta hydrodynamic diameter, polydispersity index, 
and surface charge of the magnetoplex were determined by 
dynamic light scattering using a Zetasizer Nano ZS (Malvern 
Instruments Ltd, Malvern, Worcestershire, UK) at room 
temperature. The magnetoplex was prepared and combined 
to achieve 1 mL in deionized water. All samples were mea-
sured in triplicate.
Cell culture
In this study, human neuroblastoma (LAN-5) cells were used 
as the neuronal cell culture model. The cells were cultured in 
Dulbecco’s modified Eagle’s medium (Gibco-BRL, Grand 
Island, NY) supplemented with 10% fetal bovine serum 
(HyClone, South Logan, UT) and incubated for 24 hours at 
37°C with 5% CO2 before use.
Transfection and cytotoxicity
To evaluate the transfection efficiency of the mag-PEI 
nanoparticles, LAN-5 cells were seeded into a 96-well plate 
at a density of 5 × 104 cells per well. Before transfection, the 
medium was removed, the cells were rinsed with phosphate-
buffered saline twice, and then plated and incubated with 
serum-free Dulbecco’s modified Eagle’s medium. Cells were 
incubated with the magnetoplex at 37°C for 15, 30, 60, 120, 
and 180 minutes with or without magnetoFACTOR-96, in 
serum-free medium which was then replaced with growth 
medium. Twenty-four hours after transfection,19 luciferase 
activity was determined in accordance with the manufacturer’s 
recommendations (Promega, Madison, WI). Luciferase activity 
was quantified as relative light units using a luciferase assay 
system (Promega). Luciferase activity was normalized for 
protein concentration using the Bradford assay. The commercial 
transfection reagents, Lipofectamine 2000 and PolyMAG, were 
used as positive controls for comparison of their transfection 
efficiency with our synthesized mag-PEI nanoparticles. Naked 
DNA (DNA transfected without a gene carrier) was used as 
the negative control for transfections. The Lipofectamine/DNA 
complex and PolyMAG/DNA magnetoplex were prepared 
according to the manufacturer’s directions.
MTT assays were performed to evaluate cell viability 
after treatment with magnetoplex. LAN-5 cells were seeded 
at the same density used for transfection. The cells were 
cultured at 37°C under 5% CO2 overnight. The assay was 
performed 24 hours after transfection according to the 
manufacturer’s recommendation. Percentage viability was 
calculated for cells transfected with naked DNA.
Magnetoplex internalization into cells
LAN-5 cells were seeded onto glass coverslips in 6-well plates 
at densities of 7.5 × 105 cells per well. Before transfection, the 
medium was removed, the cells were rinsed with phosphate-
buffered saline twice, and then plated and incubated with 
serum-free Dulbecco’s modified Eagle’s medium. Cells were 
incubated with rhodamine-B-isothiocyanate (RITC)-labeled 
mag-PEI nanoparticle/DNA magnetoplexes at 37°C for 
60 and 180 minutes with and without a magnetoFACTOR-96 
plate in serum-free medium which was then replaced with 
growth medium. Twenty-four hours after transfection, the 
transfected cells were stained with acridine orange then 
washed with phosphate-buffered saline twice and visualized 
under a confocal laser scanning microscope (LSM 700, Carl 
Zeiss Inc, Oberkochen, Germany) with a 100× objective lens 
under 405 nm excitation for acridine orange and 561 nm 
excitation for RITC. The results were analyzed using LSM 
700 ZEN software.
Isolation of TPH-2, cloning,  
and construction of expression vector
cDNA for the TPH-2 gene was synthesized by RT-PCR using 
human brain medulla oblongata total RNA (Clontech cDNA 
panels, BD Biosciences, Franklin Lakes, NJ) as a template. 
The RT-PCR reaction was performed using ImPromt-II™ 
reverse transcriptase in accordance with the manufacturer’s 
recommendations (Promega). The resulting cDNAs were 
used as a template for PCR using TPH-2-NheI_pGL-CMV 
and TPH-2-XbaI_pGL-CMV as forward and reverse primers, 
respectively (Table 1). The specific PCR products were then 
cloned into the pGEM-T™ easy vector (Promega) to verify 
TPH-2 sequences by restriction enzyme digestion using 
HindIII (Fermentas, Glen Burnie, MD) and XbaI (NEB, 
Hitchin, UK) as the restriction enzyme and confirmed this 
result by DNA sequencing. The TPH-2 gene was finally 
cloned into pGL3-basic containing CMV promoter/enhancer, 
generating pGL3-CMV-TPH-2.
Monitoring of TPH-2 expression  
by RT-PCR
To determine TPH-2 expression, LAN-5 cells were seeded into 
6-well plates at a density of 7.5 × 105 cells per well. pGL3-
CMV-TPH-2 was mixed with mag-PEI nanoparticles to prepare 
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magnetoplex at an N/P ratio of 0.8, which was previously 
optimized. PolyMAG and Lipofectamine 2000 were used as 
positive controls and naked DNA was used as a negative control 
for transfection. Cells were incubated with the magnetoplex 
at 37°C for 60 minutes with and without external magnetic 
induction in serum-free medium which was then replaced with 
growth medium. Twenty-four hours after transfection, RNA 
extraction with TRIzol (Invitrogen) was performed according to 
the manufacturer’s recommendations. The quantity and integrity 
of the RNA obtained were evaluated by spectrophotometry and 
gel electrophoresis stained with ethidium bromide. The RNA 
samples obtained were then treated with a deoxyribonuclease 
I amplification grade kit (P  romega) at 37°C for 30 minutes 
to eliminate any contaminated DNA. Two steps of RT-PCR 
were carried out using Impromt II reverse transcription to 
synthesize first-strand cDNA. Taq polymerase (NEB) was 
then used for PCR under the following conditions: 95°C over 
2 minutes for the TPH-2 gene and 94°C over 5 minutes for the 
GAPDH gene, followed by 35 cycles of denaturation (95°C 
over 30 seconds for the TPH-2 gene and 94°C over 15 seconds 
for the GAPDH gene), annealing (60°C over 30 seconds for 
the TPH-2 gene and 55°C over 15 seconds for the GAPDH 
gene), extension (68°C over 30 seconds for the TPH-2 gene 
and 72°C over 15 seconds for the GAPDH gene), and finally a 
single extension (68°C over 10 minutes for the TPH-2 gene and 
72°C for 15 minutes for the GAPDH gene). A control negative 
RT-PCR was performed in the absence of reverse transcriptase 
to check for DNA contamination in the RNA preparation. Each 
TPH-2 expression was normalized against expression of the 
GADPH gene to eliminate the effect of the cell population. 
Each relative TPH-2 expression was then compared with naked 
DNA transfected cells.
Statistical analysis
Experiments were carried out in triplicate. The independent 
Student’s t-test was used for the statistical analysis, with 
P , 0.05 considered to be statistically significant.
Results and discussion
Fabrication of core shell nanoparticles
Transmission electron microscopy revealed that we could 
obtain magnetic polymeric core/shell nanospheres, ie, 
mag-PEI nanoparticles, with high magnetic nanoparticle 
loading (Figure 1). The size distribution was found to be 
narrow, as indicated in the histogram. The zeta potential 
determined by dynamic light scattering indicated that the 
mag-PEI nanoparticles had positive surface charges around 
39.3 ± 1.9 mV .
Gel retardation assay
DNA binding affinity and magnetoplex formation were 
confirmed using the gel retardation assay. One microgram of 
plasmid pGL3-basic containing the CMV promoter/enhancer 
was applied to a prepared magnetoplex with mag-PEI nano-
particles at different N/P ratios. Trailing of DNA disappeared 
in the gel at an N/P ratio of 0.8/1 (Figure 2). The results 
showed that plasmid DNA was adsorbed onto the mag-PEI 
nanoparticle surface by electrostatic interaction, resulting in 
the magnetoplex. Our cationic mag-PEI nanoparticles could 
neutralize the negative charge of plasmid DNA and increase 
the mag-PEI nanoparticle-induced cationic properties of the 
magnetoplex, corresponding to the results of the dynamic 
light scattering analysis (Table 2).
Figure 1 Transmission electron microscopic image. (A) Mag-PEI and histogram 
showing size distribution. (B) Mag-PEI nanoparticles with high magnetic loading.
Abbreviation: Mag-PEI, magnetic poly(methyl methacrylate) core/  polyethyleneimine 
shell.
Figure 2 Gel retardation assay. 
Notes: One microgram of plasmid DNA was applied to the magnetoplex with mag-
PEI nanoparticles at different N/P ratios. Lane 1 is the control DNA without mag-
PEI nanoparticles. Lanes 2–7 represent mag-PEI NP/DNA magnetoplexes with N/P 
ratios of 0.4/1, 0.8/1, 1.6/1, 4.3/1, 8.7/1, and 17.5/1.
Abbreviation: Mag-PEI, magnetic poly(methyl methacrylate) core/polyethyleneimine 
shell.
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Magnetoplex formation
The morphology and size of the magnetoplex were analyzed 
under atomic force microscopy at two different N/P ratios, 
ie, 0.8 and 4.3. Atomic force microscopy detected that the 
magnetoplex appearance was spherical, corresponding to 
the core structures, ie, mag-PEI nanoparticles (Figure 3). 
It is likely that addition of more mag-PEI nanoparticles 
with N/P ratios in the range of 0.8/1–4.3/1 could improve 
the magnetoplex condensation. This result correlated well 
with size analyzed by dynamic light scattering (Table 2). 
However, magnetoplex distribution changed in response to 
changes in the N/P ratio, as shown at ratios of 0.8/1 and 4.3/1 
(Figure 3). As a result, use of excess mag-PEI nanoparticles 
caused aggregation of the magnetoplex (Figure 3C), which 
may have interrupted cell transfection. Therefore, the mag-
netoplex formed at an N/P ratio of 0.8/1 was selected for cell 
transfection in further studies.
Size and zeta potential analysis
The size and zeta potential of the magnetic nanoparticles 
were determined at pH 7.4. During magnetoplex   formation, 
a dynamic change in size and charge occurred at N/P ratios 
in the range of 0.4–17.5 (Table 2). The size of the mag-PEI/
DNA was larger than that of mag-PEI, indicating that adsorp-
tion of DNA had occurred on the particle   surface. With a 
constant amount of DNA, the total charges at each N/P ratio 
were dependent on the amount of mag-PEI nanoparticles 
added to the DNA solution. At N/P ratios in the 0.4–1.6 
range, the charges increased according to the amount of 
mag-PEI nanoparticles added. However, at N/P ratios in the 
range of 4.3–17.5, the excess amount of mag-PEI nanopar-
ticles destabilized the complex, as indicated by a decrease 
in zeta potential.
Optimal transfection conditions  
and transfection efficiency
Gene transfection was investigated in the human LAN-5 
neuroblastoma cell line. Cells were transfected with the 
magnetoplex at an optimal N/P ratio of 0.8. Gene transfec-
tion was performed by incubation of the magnetoplex with 
cells for 15, 30, 60, 120, and 180 minutes in the presence 
and absence of an external magnetic plate. Transfection via 
Lipofectamine 2000 and PolyMAG, two commercial trans-
fection reagents, was carried out in the positive controls. 
Table 2 Size and zeta potential of mag-PEI nanoparticle/DNA magnetoplex at N/P ratios of 0.4/1, 0.8/1, 1.6/1, 4.3/1, 8.7/1, and 17.5/1
N/P Size (nm) Zeta potential (mV) PDI
Mag-PEI NP 123.8 ± 3.1 39.3 ± 1.9 0.26 ± 0.02
Mag-PEI NP/DNA 0.4/1 231.3 ± 24.7 6.3 ± 1.7 0.36 ± 0.03
  0.8/1 370.0 ± 32.4 25 ± 1.4 0.45 ± 0.05
  1.6/1 298.5 ± 65 34.8 ± 2.3 0.75 ± 0.15
  4.3/1 286.8 ± 23.3 22.4 ± 3.2 0.42 ± 0.06
  8.7/1 251.3 ± 5.1 5.6 ± 0.5 0.34 ± 0.06
  17.5/1 215.4 ± 17.5 3.3 ± 0.7 0.36 ± 0.05
Abbreviations: Mag-PEI NP, magnetic poly(methyl methacrylate) core/polyethyleneimine shell nanoparticles; PDI, polydispersity index.
N/P = 4.3/1 N/P = 0.8/1 Mag-PEI NP
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Figure 3 Atomic force microscopy images of mag-PEI nanoparticles (A) mag-PEI nanoparticles forming magnetoplexes with DNA at N/P ratios of 0.81/1 (B) and 4.3/1 (C).
Abbreviation: Mag-PEI, magnetic poly(methyl methacrylate) core/polyethyleneimine shell.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2788
Tencomnao et alInternational Journal of Nanomedicine 2012:7
Luciferase signals expressed in transfected cells were 
determined quantitatively. At all tested N/P ratios, the 
results confirm that magnetic-induced transfection was a 
very effective system for gene transfection (Figure 4A). 
Luciferase expression levels were enhanced when DNA 
transfections were stimulated under magnetic force using the 
magnetoFACTOR-96 plate. Our results show that incorpora-
tion of magnetic nanoparticles in polymeric-based vectors 
is an effective strategy to elevate the transfection signal and 
shorten the transfection time. The efficiency of gene trans-
fection was increased through physical stimulation by an 
external magnetic field. Among the N/P ratios in the range 
of 0.4–17.5, the highest transfection efficiency was obtained 
at an N/P ratio of 0.8. This result indicates that transfection 
efficiency was affected by several physicochemical proper-
ties of the magnetoplex. With a low amount of mag-PEI 
nanoparticles (N/P ratio , 0.8), the DNA strands are not 
completely adsorbed onto the nanoparticles. Therefore, the 
DNA delivered into the cells is not properly protected and 
easily digested by intracellular enzymes. The N/P ratio of 
0.8 is probably the optimal condition, including for size, zeta 
potential, and complex stability. Although at an N/P ratio 
of 1.6–4.3 the magnetoplex also has an appropriate size and 
zeta potential, it can also cause cell membrane damage due 
to the greater number of nanoparticles with a positive surface 
charge added to the system. Furthermore, the atomic force 
microscopy results indicated that the magnetoplex at an N/P 
ratio of 4.3 was agglomerated, which was an unsuitable con-
dition for transfection. Therefore, to obtain high transfection 
efficiency, several factors needed to be compromised.
Unlike for PolyMAG, the results indicate that the 
increased transfection efficiency for mag-PEI nanoparticles 
is time-dependent. PolyMAG is a commercially available 
carrier enhancing the transfection signal within a short 
induction time, and expression levels are fairly constant at 
different incubation times. The difference in improvement 
of transfection over time is probably due to the difference 
in magnetic properties between PolyMAG and mag-PEI 
  nanoparticles. PolyMAG has very strong magnetic properties, 
which strongly enforces cell internalization of particles into 
the cell within a short time. However, after 120 minutes of 
induction, the transfection efficiency obtained from mag-PEI 
nanoparticles was about the same level as that obtained from 
PolyMAG, and was increased after 180 minutes of induc-
tion time. Apparently, for LAN-5 cells, a magnetic-assisted 
transfection system is more effective than a liposome-based 
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Figure 4 Transfection efficiency (A) and cytotoxicity (B) of mag-PEI nanoparticles at 15, 30, 60, 120, and 180 minutes in LAN-5 cells.
Notes: The transfection efficiency and cytotoxicity was compared with positive control Lipofectamine 2000™, PolyMAG, and negative controls (naked DNA, plasmid pGL-
3-basic containing CMV promoter/enhancer). *Significant differences between cells transfected with and without a magnetic plate in each transfection reagent (P , 0.05). 
The gray and white bars show the results of cells incubated with or without magnetic induction, respectively.
Abbreviation: Mag-PEI, magnetic poly(methyl methacrylate) core/polyethyleneimine shell.
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system like Lipofectamine 2000, and there was no statisti-
cally significant difference between cells transfected with 
and without a magnetic plate.
Evaluation of cytotoxicity
In this study, the toxicity of mag-PEI nanoparticles towards 
LAN-5 cells was investigated using the MTT assay. Cells 
were treated with the magnetoplex under the same conditions 
as the transfection procedures. The viability of LAN-5 cells 
after transfection was in the range of 80%–100% when incu-
bated with magnetoplex at N/P ratios of 0.4/1, 0.8/1, 1.6/1, 
4.3/1, 8.7/1, and 17.5/1 for 15, 30, 60, 120, and 180 minutes 
(Figure 4B). Viability of cells exposed to magnetic induction 
was lower than that of unexposed cells. However, the differ-
ences were not statistically significant. Therefore, this result 
verifies that the cytotoxicity of mag-PEI nanoparticles is very 
low, making these particles suitable for use in gene therapy.
Cellular internalization
Visualization of uptake of mag-PEI nanoparticles into 
LAN-5 cells was observed by confocal laser scanning 
  microscopy. The RITC-labeled mag-PEI nanoparticle/DNA 
magnetoplex at an N/P ratio of 0.8/1 was incubated with 
the cells for 60 and 180 minutes. The incubations were 
done separately with and without external magnetic induc-
tion. At 24 hours after transfection, confocal laser scanning 
microscopy images revealed the degree of intensity of the 
magnetoplex entering into LAN-5 cells (Figure 5). At both 
60 and 180   minutes of incubation, the intensities were sig-
nificantly increased when transfection was performed under 
magnetic induction. The results indicate that the magnetoplex 
distributed into the intracellular compartment, the cytoplasm, 
and the region of the nucleus. Internalization was confirmed by 
confocal Z-stack image scanning (data not shown). The result 
corresponded well with the luciferase activity in Figure 4A. 
This provides more evidence of acceleration of the transfection 
period through magnetoplex transfection in neuronal cells.
TPH-2 cloning
cDNA synthesized from human brain medulla oblongata total 
RNA was used as a template for synthesizing the TPH-2 gene 
fragment. PCR was performed using the specific primers 
described in Table 1. The PCR product showed a specific 
band at 1.5 kilobases under an ultraviolet transilluminator 
(Syngene, Cambridge, UK). The band was cut and ligated 
into a pGEM®-T vector (Promega). DNA sequencing veri-
fied that the isolated PCR product had 99.5% similarity to 
Homo sapiens TPH-2 mRNA. The TPH-2 gene was then 
finally transferred into pGL3-CMV basic containing the 
CMV promoter/enhancer.19 The resulting plasmid was used 
for gene transfection into LAN-5 cells.
Role of mag-PEI nanoparticles  
as a carrier for TPH-2 expression
The aforementioned data indicate that mag-PEI nanoparticles 
are a promising carrier for magnetic-assisted transfection 
due to their effectiveness, with low cytotoxicity and a short 
transfection time. We are continuing to test mag-PEI nano-
particles at an N/P ratio of 0.8/1 as a carrier for delivery 
of the neuronal TPH-2 therapeutic gene into LAN-5 cells. 
The magnetic induction time was fixed at 60 minutes. After 
transfection, the cells were incubated for 24 hours and total 
RNA was isolated by the TRIzol reagent, as described earlier. 
Expression of the TPH-2 gene was measured by RT-PCR 
using isolated total RNA as a template. PCR products from 
the housekeeping gene, GAPDH, were used to normalize the 
gene expression values. As a result, mag-PEI nanoparticles 
showed efficiency in induction of TPH-2 expression compa-
rable with that of PolyMAG (Figure 6). Cells transfected with 
the mag-PEI nanoparticle/pGL3-CMV-TPH-2 magnetoplex 
60 minutes
180 minutes
Magnet (–)
Magnet (+)
Magnet (–)
Magnet (+)
20 µm
20 µm2 0 µm
20 µm 20 µm 20 µm
20 µm
20 µm 20 µm
20 µm2 0 µm2 0 µm
B
A
Figure 5 Confocal image of LAN-5 cells 24 hours after transfection. Cells incubated 
with or without a magnetic plate for (A) 60 minutes and (B) 180 minutes were used 
for investigation of the cellular uptake of mag-PEI nanoparticles.
Note:  Green,  acridine  orange-stained  live  cells;  red,  RITC-stained  mag-PEI 
nanoparticles.
Abbreviations: RITC, rhodamine-B-isothiocyanate; Mag-PEI, magnetic poly(methyl 
methacrylate) core/polyethyleneimine shell.
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under magnetic induction showed a signal that was 13 times 
stronger than that obtained without induction. We compared 
the effectiveness of mag-PEI nanoparticles for therapeutic 
gene delivery with that of a liposome-based system, ie, 
Lipofectamine 2000. The results show that the difference 
between TPH-2 expression in cells transfected with and 
without magnetic induction was not significantly different. 
Therefore, this study demonstrates the potential of our syn-
thesized nanoparticle for magnet-assisted gene transfection. 
Mag-PEI nanoparticles successfully enhanced the transfec-
tion efficiency of TPH-2 gene delivery.
Conclusion
In this study, we demonstrated the potential of mag-PEI nano-
particles, possessing high saturation magnetization, for gene 
transfection in vitro. The mag-PEI nanoparticles at an N/P 
ratio of 0.8/1 showed the highest transfection efficiency and 
low cytotoxicity in neuronal LAN-5 cells. The results obtained 
from the luciferase assay were consistent with those of the 
cell internalization investigation by confocal laser scanning 
microscopy. Significant acceleration of transfection efficiency 
within a short induction time revealed that mag-PEI nanopar-
ticles are a promising alternative carrier for gene delivery. 
This newly improved magnetic nanoparticle is suitable for 
magnetic-assisted transfection, which may be further applied 
in gene therapy for neuropsychiatric and other diseases.
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